# FDA recall D-0519-2017

> **G & W  Laboratories, Inc.** · Class III · drug recall initiated 2017-02-28.

## Product

Clindamycin Phosphate Topical Solution USP, 1%, packaged in a) 30 mL applicator bottles (NDC 0472-0987-91) and b) 60 mL applicator bottles (NDC 0472-0987-92), Rx Only, Manufactured by: G&W Laboratories, Inc., 111 Coolidge Street, South Plainfield, NJ 07080; Distributed by: Actavis Mid Atlantic LLC, 1877 Kawai Road, Lincolnton, NC 28092.

## Reason for recall

CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.

## Distribution

Nationwide in the USA.

## Key facts

- **Recall number:** D-0519-2017
- **Recalling firm:** G & W  Laboratories, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-02-28
- **Report date:** 2017-03-22
- **Termination date:** 2017-12-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** South Plainfield, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0519-2017

## Citation

> AI Analytics. FDA recall D-0519-2017. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0519-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*